A non-conserved amino acid variant regulates differential signalling between human and mouse CD28-Reference-Cited by-同舟云学术

A non-conserved amino acid variant regulates differential signalling between human and mouse CD28

Published:2018-03-14 Issue:1 Volume:9 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Porciello Nicla,Grazioli Paola,Campese Antonio F.,Kunkl Martina,Caristi Silvana,Mastrogiovanni Marta,Muscolini Michela,Spadaro Francesca,Favre Cédric,Nunès Jacques A.^ORCID,Borroto Aldo,Alarcon Balbino,Screpanti Isabella,Tuosto Loretta

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-018-03385-8.pdf

Reference54 articles.

1. Viola, A., Contento, R. L. & Molon, B. Signaling amplification at the immunological synapse. Curr. Top. Microbiol. Immunol. 340, 109–122 (2010).

2. Porciello, N. & Tuosto, L. CD28 costimulatory signals in T lymphocyte activation: emerging functions beyond a qualitative and quantitative support to TCR signalling. Cytokine Growth Factor Rev. 28, 11–19 (2016).

3. Tuosto, L. NF-kappaB family of transcription factors: biochemical players of CD28 co-stimulation. Immunol. Lett. 135, 1–9 (2011).

4. Kallikourdis, M. et al. Phosphatidylinositol 4-phosphate 5-kinase β controls recruitment of lipid rafts into the immunological synapse. J. Immunol. 196, 1955–1963 (2016).

5. Muscolini, M. et al. Phosphatidylinositol 4-phosphate 5-kinase alpha activation critically contributes to CD28-dependent signaling responses. J. Immunol. 190, 5279–5286 (2013).

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD28 co-stimulation: novel insights and applications in cancer immunotherapy;Nature Reviews Immunology;2024-07-25

2. Abstract 5292: CD28 humanized mouse model for efficacy and safety assessment of CD28-targeting therapies;Cancer Research;2024-03-22

3. Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies;Nature Cancer;2024-03-19

4. Immune function assessing of TIM3/CD28‐modified CD19 CAR‐T cells and general CD19 CAR‐T cells through a high‐throughput single‐cell microarray platform;Interdisciplinary Medicine;2024-01

5. Weak response of bovine hepcidin induction to iron through decreased expression of Smad4;The FASEB Journal;2023-10-06